Tag Archives: Defective Drug Lawsuit

Featured Stories

New Study Links Metal-on-Metal Hip Replacement Corrosion with Adverse Local Tissue Reactions

Yet another study is pointing to potential dangers posed by metal-on-metal hip implants. This time, an article published in the Journal of Arthroplasty is reporting corrosion in the head taper junction was more likely to occur in patients with 36-mm diameter metal-on-metal hip replacement, compared to those with the same ...

Read More

Bisphosphonate Study Confirms Atypical Thigh Fracture Risk

New research has confirmed the link between bisphoshonates, such as Fosamax, and atypical femur fractures, a type of thigh fracture that occurs spontaneously, without any major leg injury. The study, published in the Archives of Internal Medicine, also found that the risk of atypical thigh fractures increases the longer a ...

Read More

FDA Warning for Bone Graft Products in Patients Under 18

FDA Safety Warning for Bone Graft Products in Patients Under 18

FDA issued safety alerts to patients, parents & guardians, bone graft devices w/recombinant proteins or synthetic peptides not to be the first treatment for 18 & under.

Read More

Medtronic Plans Layoffs, as Infuse Bone Graft Controversy Continues to Weigh on Spinal Business

Medtronic’s spinal division continues to take a huge hit thanks to the controversy surrounding its Infuse Bone Graft product. According to a report from MassDevice.com, the company’s latest earnings report stated that the division saw Infuse sales decline 26% in the first quarter of 2012, and now Medtronic is talking ...

Read More

British Recall of Smith & Nephew Renasys Wound Care System

British Recall of Smith & Nephew Renasys Wound Care System for Infection Risk

The MHRA announced the recall of Smith & Nephew Renasys wound care devices - risk of maceration, infection, loss of negative pressure, or unrecognized bleeding in wounds.

Read More

Dozens Receive Nonsterile Simulated Saline Solution

Dozens-Receive-Nonsterile-Simulated-Saline-Solution

The FDA said last week that more than 40 patients had received intravenous simulated saline that was not sterile and was not intended for human use.

Read More

Metal-on-Metal Hip Implant Lawyer Takes Issue with Statements Made by DePuy Orthpaedics Official During FDA Meeting

An attorney with a national law firm that represents victims of alleged metal-on-metal hip implant injuries has expressed dismay at some statements made last week regarding the regulation of all-metal hip replacement devices by an official with DePuy Orthopaedics. According to Daniel Burke, Senior Litigation Counsel at Parker ...

Read More

Study Suggests Hormonal Contraceptives Linked to Brain Tumor

Study Suggests Hormonal Contraceptives Linked to Increased Brain Tumor Risk

A study of Danish women of reproductive age suggests that long-term use of hormonal contraceptives is associated with an increased risk of brain tumors.

Read More

Tennessee Resident Files Pradaxa Bleeding Lawsuit Following Cerebral Hemorrhage

A man from Tennessee has filed a lawsuit against the maker of Pradaxa, claiming that the blood thinner caused him to suffer a cerebral hemorrhage. The complaint alleges Boehringer Ingelheim Pharmaceuticals, Inc. concealed knowledge that Pradaxa can cause Serious, life-threatening bleeds, and did not warn that Pradaxa bleeding side effects ...

Read More

Pradaxa Named in Most FDA Adverse Event Reports for Deaths, Hemorrhage, Kidney Failure and Stroke

The controversial blood thinner, Pradaxa, surpassed all other drugs monitored by the U.S. Food & Drug Administration (FDA) in adverse event reports made to the agency last year. According to the Institute for Safe Medicine Practices’ (ISMP) latest QuarterWatch report, Pradaxa also topped the list for reports of deaths, ...

Read More

Proton Pump Inhibitors May Lower Magnesium Levels, FDA Warns

< "http://www.yourlawyer.com/topics/overview/Proton_pump_inhibitors">Proton pump inhibitors can lower magnesium levels if the popular heartburn drugs are used over a long period of time, the U.S. Food & Drug Administration (FDA) has warned. Low serum magnesium levels (hypomagnesemia) can result in serious health … Continue reading

Posted in Pharmaceuticals, Proton Pump Inhibitors | Tagged , , , , , |

Users of Plavix, Valium, Other Meds Could Suffer Reactions if they Carry CYP2C19 Gene Variant

Does a gene variant explain a U.S. lawmaker’s odd behavior? According to Rep. David Wu, an Oregon Democrat, a variant in the CYP2C19 gene, which plays a role in metabolizing some drugs, like < "http://www.yourlawyer.com/topics/overview/Plavix-Cerebral-Gastrointestinal-Bleeding-Hemorrhaging-Lawsuit-Lawyer">Plavix and Valium was the reason … Continue reading

Posted in Pharmaceuticals | Tagged , , , , , |

Stevens-Johnson Syndrome Follows Teen’s Use of Eye Drops

A 19-year-old girl in the United Kingdom required weeks of intensive care treatment and is looking at months of follow-up treatment following a dangerous drug reaction called < "http://www.yourlawyer.com/topics/overview/stevens_johnson_syndrome">Stevens-Johnson syndrome after using Optrex eye drops. According to the Voice Online, … Continue reading

Posted in Pharmaceuticals | Tagged , , , , , |

Abacavir Safety Review Shows No Heart Attack Link, Conflicts with Some Earlier Studies

U.S. health regulators said today said that a safety review did not find a connection between < "http://www.yourlawyer.com/practice_areas/defective_drugs">abacavir and an increased risk of heat attacks. Abacavir—sold under brand names Ziagen, Trizivir, and Epzicom – is used in the treatment of … Continue reading

Posted in Pharmaceuticals | Tagged , , , |

Multaq Patients Should Undergo Liver Function Tests

European regulators recently warned that < "http://www.yourlawyer.com/topics/overview/multaq-dronedarone-liver-damage-failure-lawsuit-lawyer-attorney">Multaq (donedarone) could put patients at risk for severe liver injuries. The European Medicines Agency (EMA) is now recommending that doctors perform liver function tests before treating atrial fibrillation patients with Multaq. The European … Continue reading

Posted in Multaq, Pharmaceuticals | Tagged , , , , |

Avastin Breast Cancer Decision Will Be Appealed in June

The maker of < "http://www.yourlawyer.com/topics/overview/Avastin-Side-Effects-Lawyers-Lawsuit-Attorney">Avastin will attempt this summer to convince the U.S. Food & Drug Administration (FDA) that it made a mistake when it decided to revoke the pricey drug’s approval as a treatment for advanced breast cancer. Roche’s … Continue reading

Posted in Legal News | Tagged , , , , , |

Extenze Tablets Recalled for Undeclared Ingredient

Biotab Nutraceuticals, Inc. is conducting a voluntary recall of two lots of < "http://www.yourlawyer.com/practice_areas/defective_drugs">Extenze Nutritional Supplement Tablets, the U.S. Food and Drug Administration (FDA) just announced. Some packages bearing lot numbers 0709241 and 0509075 are counterfeit products containing undeclared drug … Continue reading

Posted in Pharmaceuticals | Tagged , , , , , |

Acetaminophen, Ibuprofen Should be taken with Caution

< "http://www.yourlawyer.com/topics/overview/Acetaminophen-Liver-Damage-Injury-Failure-Lawsuit-Lawyer">Acetaminophen and ibuprofen, painkillers found in just about everyone’s medicine cabinet, can cause some serious side effects. Acetaminophen, the active ingredient Tylenol and other over-the-counter drugs, as well as some prescription painkillers, can cause serious liver damage if too … Continue reading

Posted in Acetaminophen / Tylenol | Tagged , , , , |

Osteoporosis Drugs Linked to Thigh Fractures, Yet Again

Bone loss drugs in the class of < "http://www.yourlawyer.com/topics/overview/Bisphosphonates">bisphosphonates have, again, been linked to bone fractures of the femur (thigh bone). Web MD said that a recent, large review of over 200,000 post-menopausal women found that those taking bisphosphonates—drugs sold … Continue reading

Posted in Bisphosphonates, Pharmaceuticals | Tagged , , , , , |

Antipsychotic Drugs Pose Risks to Newborns, FDA Says

U.S. health regulators have ordered that cautions be added to the labels of ALL antipsychotic drugs regarding their risk of abnormal muscle movements (extrapyramidal symptoms or EPS) and withdrawal syndromes in newborns when used in pregnancy. The new cautions will … Continue reading

Posted in Pharmaceuticals | Tagged , , , , , |

© 2005-2017 Parker Waichman LLP ®. All Rights Reserved.